Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""MYOCARDIAL infarction"" wg kryterium: Temat


Tytuł :
Microthrombi as a Major Cause of Cardiac Injury in COVID-19: A Pathologic Study.
Autorzy :
Pellegrini D; Ospedale Papa Giovanni XXIII, Bergamo, Italy (D.P., G.G., A.G., A.N., L.F., I.P., M.B.).
Kawakami R; CVPath Institute, Inc, Gaithersburg, MD (R.K., A.S., K.K., R.K., L.G., A.C., M.M., Y.S., M.R., R.V., A.V.F.).
Guagliumi G; Ospedale Papa Giovanni XXIII, Bergamo, Italy (D.P., G.G., A.G., A.N., L.F., I.P., M.B.).
Sakamoto A; Ospedale Papa Giovanni XXIII, Bergamo, Italy (D.P., G.G., A.G., A.N., L.F., I.P., M.B.).; CVPath Institute, Inc, Gaithersburg, MD (R.K., A.S., K.K., R.K., L.G., A.C., M.M., Y.S., M.R., R.V., A.V.F.).
Kawai K; CVPath Institute, Inc, Gaithersburg, MD (R.K., A.S., K.K., R.K., L.G., A.C., M.M., Y.S., M.R., R.V., A.V.F.).
Gianatti A; Ospedale Papa Giovanni XXIII, Bergamo, Italy (D.P., G.G., A.G., A.N., L.F., I.P., M.B.).
Nasr A; Ospedale Papa Giovanni XXIII, Bergamo, Italy (D.P., G.G., A.G., A.N., L.F., I.P., M.B.).
Kutys R
Guo L; CVPath Institute, Inc, Gaithersburg, MD (R.K., A.S., K.K., R.K., L.G., A.C., M.M., Y.S., M.R., R.V., A.V.F.).
Cornelissen A; CVPath Institute, Inc, Gaithersburg, MD (R.K., A.S., K.K., R.K., L.G., A.C., M.M., Y.S., M.R., R.V., A.V.F.).
Faggi L; Ospedale Papa Giovanni XXIII, Bergamo, Italy (D.P., G.G., A.G., A.N., L.F., I.P., M.B.).
Mori M; CVPath Institute, Inc, Gaithersburg, MD (R.K., A.S., K.K., R.K., L.G., A.C., M.M., Y.S., M.R., R.V., A.V.F.).
Sato Y; CVPath Institute, Inc, Gaithersburg, MD (R.K., A.S., K.K., R.K., L.G., A.C., M.M., Y.S., M.R., R.V., A.V.F.).
Pescetelli I; Ospedale Papa Giovanni XXIII, Bergamo, Italy (D.P., G.G., A.G., A.N., L.F., I.P., M.B.).
Brivio M; Ospedale Papa Giovanni XXIII, Bergamo, Italy (D.P., G.G., A.G., A.N., L.F., I.P., M.B.).
Romero M; CVPath Institute, Inc, Gaithersburg, MD (R.K., A.S., K.K., R.K., L.G., A.C., M.M., Y.S., M.R., R.V., A.V.F.).
Virmani R; CVPath Institute, Inc, Gaithersburg, MD (R.K., A.S., K.K., R.K., L.G., A.C., M.M., Y.S., M.R., R.V., A.V.F.).
Finn AV; CVPath Institute, Inc, Gaithersburg, MD (R.K., A.S., K.K., R.K., L.G., A.C., M.M., Y.S., M.R., R.V., A.V.F.).; University of Maryland, Baltimore (A.V.F.).
Pokaż więcej
Źródło :
Circulation [Circulation] 2021 Mar 09; Vol. 143 (10), pp. 1031-1042. Date of Electronic Publication: 2021 Jan 22.
Typ publikacji :
Journal Article
MeSH Terms :
Myocardial Infarction*/pathology
Myocardial Infarction*/virology
COVID-19/*virology
Coronary Thrombosis/*etiology
Myocardium/*pathology
Aged ; COVID-19/pathology ; Coronary Thrombosis/pathology ; Coronary Thrombosis/virology ; Coronary Vessels/pathology ; Coronary Vessels/virology ; Female ; Heart/virology ; Humans ; Italy ; Male ; Middle Aged ; SARS-CoV-2 ; ST Elevation Myocardial Infarction/epidemiology ; ST Elevation Myocardial Infarction/virology
Czasopismo naukowe
Tytuł :
Comparison of Hospitalization Trends and Outcomes in Acute Myocardial Infarction Patients With Versus Without Opioid Use Disorder.
Autorzy :
Ranka S; Department of Cardiovascular Medicine, The University of Kansas Health System, University of Kansas School of Medicine, Kansas City, Kansas.
Dalia T; Department of Cardiovascular Medicine, The University of Kansas Health System, University of Kansas School of Medicine, Kansas City, Kansas.
Acharya P; Department of Cardiovascular Medicine, The University of Kansas Health System, University of Kansas School of Medicine, Kansas City, Kansas.
Taduru SS; Department of Cardiovascular Medicine, The University of Kansas Health System, University of Kansas School of Medicine, Kansas City, Kansas.
Pothuru S; Department of Medicine, Ascension Via Christi Hospital, Manhattan, Kansas.
Mahmood U; Department of Medicine, The University of Kansas Health System, Kansas City, Kansas.
Stack B; Kansas University School of Medicine, Kansas City, Kansas.
Shah Z; Department of Cardiovascular Medicine, The University of Kansas Health System, University of Kansas School of Medicine, Kansas City, Kansas.
Gupta K; Department of Cardiovascular Medicine, The University of Kansas Health System, University of Kansas School of Medicine, Kansas City, Kansas. Electronic address: .
Pokaż więcej
Źródło :
The American journal of cardiology [Am J Cardiol] 2021 Apr 15; Vol. 145, pp. 18-24. Date of Electronic Publication: 2021 Jan 14.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Hospital Mortality*
Myocardial Revascularization/*statistics & numerical data
Non-ST Elevated Myocardial Infarction/*epidemiology
Opioid-Related Disorders/*epidemiology
ST Elevation Myocardial Infarction/*epidemiology
Shock, Cardiogenic/*epidemiology
Acute Kidney Injury/epidemiology ; Aged ; Cardiac Catheterization/statistics & numerical data ; Comorbidity ; Coronary Artery Bypass/statistics & numerical data ; Drug-Eluting Stents/statistics & numerical data ; Female ; Hospitalization/trends ; Humans ; Logistic Models ; Male ; Middle Aged ; Multivariate Analysis ; Myocardial Infarction/epidemiology ; Myocardial Infarction/therapy ; Non-ST Elevated Myocardial Infarction/therapy ; Outcome Assessment, Health Care ; Percutaneous Coronary Intervention/statistics & numerical data ; Prevalence ; ST Elevation Myocardial Infarction/therapy ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Unraveling the thread of uncontrolled immune response in COVID-19 and STEMI: an emerging need for knowledge sharing.
Autorzy :
Rios-Navarro C; INCLIVA Health Research Institute, University of Valencia, Valencia, Spain.
Dios E; Department of Medicine, School of Medicine, University of Valencia, Valencia, Spain.; Centro de Investigación Biomédica en Red-Cardiovascular, University of Valencia, Valencia, Spain.
Forteza MJ; Department of Medicine, Center of Molecular Medicine, Cardiovascular Medicine Unit, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Bodi V; INCLIVA Health Research Institute, University of Valencia, Valencia, Spain.; Department of Medicine, School of Medicine, University of Valencia, Valencia, Spain.; Centro de Investigación Biomédica en Red-Cardiovascular, University of Valencia, Valencia, Spain.; Cardiology Department, Hospital Clinico Universitario, University of Valencia, Valencia, Spain.
Pokaż więcej
Źródło :
American journal of physiology. Heart and circulatory physiology [Am J Physiol Heart Circ Physiol] 2021 Jun 01; Vol. 320 (6), pp. H2240-H2254. Date of Electronic Publication: 2021 Apr 12.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
COVID-19/*immunology
Immune System/*physiopathology
ST Elevation Myocardial Infarction/*immunology
COVID-19/complications ; Humans ; Inflammation/etiology ; Inflammation/therapy ; Myocardial Infarction/etiology ; ST Elevation Myocardial Infarction/complications
Czasopismo naukowe
Tytuł :
Long-Term Prognosis in Young Patients with Acute Coronary Syndrome Treated with Percutaneous Coronary Intervention.
Autorzy :
Yagel O; Department of Cardiology, Hadassah Medical Center, Jerusalem, Israel; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Shadafny N; Department of Cardiology, Hadassah Medical Center, Jerusalem, Israel; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Eliaz R; Department of Cardiology, Hadassah Medical Center, Jerusalem, Israel; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Dagan G; Department of Cardiology, Hadassah Medical Center, Jerusalem, Israel; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Leibowitz D; Department of Cardiology, Hadassah Medical Center, Jerusalem, Israel; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Tahiroglu I; Department of Cardiology, Hadassah Medical Center, Jerusalem, Israel; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Planer D; Department of Cardiology, Hadassah Medical Center, Jerusalem, Israel; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Amir O; Department of Cardiology, Hadassah Medical Center, Jerusalem, Israel; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Elbaz Greener G; Department of Cardiology, Hadassah Medical Center, Jerusalem, Israel; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Alcalai R; Department of Cardiology, Hadassah Medical Center, Jerusalem, Israel; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Pokaż więcej
Źródło :
Vascular health and risk management [Vasc Health Risk Manag] 2021 Apr 19; Vol. 17, pp. 153-159. Date of Electronic Publication: 2021 Apr 19 (Print Publication: 2021).
Typ publikacji :
Journal Article
MeSH Terms :
Percutaneous Coronary Intervention*/adverse effects
Percutaneous Coronary Intervention*/mortality
Acute Coronary Syndrome/*therapy
Angina, Unstable/*therapy
ST Elevation Myocardial Infarction/*therapy
Acute Coronary Syndrome/diagnostic imaging ; Acute Coronary Syndrome/mortality ; Adult ; Age of Onset ; Angina, Unstable/diagnostic imaging ; Angina, Unstable/mortality ; Databases, Factual ; Female ; Humans ; Male ; Non-ST Elevated Myocardial Infarction/diagnostic imaging ; Non-ST Elevated Myocardial Infarction/mortality ; Non-ST Elevated Myocardial Infarction/therapy ; Recurrence ; Retrospective Studies ; Risk Assessment ; Risk Factors ; ST Elevation Myocardial Infarction/diagnostic imaging ; ST Elevation Myocardial Infarction/mortality ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Post-PCI outcomes in STEMI patients with coronary ectasia: meta-analysis.
Autorzy :
Mir T; Department of Internal Medicine, Detroit Medical Center, Wayne State University, Detroit, USA.
Sattar Y; Department of Internal medicine, Icahn School of Medicine at Mount Sinai, New York, USA.
Uddin M; Department of Internal Medicine, Detroit Medical Center, Wayne State University, Detroit, USA.
Changal KH; Department of Cardiovascular Medicine, University of Toledo Health Sciences, Toledo, USA.
Kumar K; Department of Cardiovascular Medicine, Detroit Medical Center, Wayne State University, Detroit, USA.
Attique HB; Department of Internal Medicine, University of Connecticut, Farmington, USA.
Kabashneh S; Department of Internal Medicine, Detroit Medical Center, Wayne State University, Detroit, USA.
Ullah W; Department of Internal Medicine, Abington Jefferson Health, Abington, PA, USA.
Lohia P; Department of Internal Medicine, Detroit Medical Center, Wayne State University, Detroit, USA.
Alraies MC; Department of Cardiovascular Medicine, Detroit Medical Center, Wayne State University, Detroit, USA.
Blank N; Department of Cardiovascular Medicine, Detroit Medical Center, Wayne State University, Detroit, USA.
Afonso L; Department of Cardiovascular Medicine, Detroit Medical Center, Wayne State University, Detroit, USA.
Qureshi WT; Department of Cardiology,University of Massachusetts School of Medicine, Worcester, MA, USA.
Pokaż więcej
Źródło :
Expert review of cardiovascular therapy [Expert Rev Cardiovasc Ther] 2021 Apr; Vol. 19 (4), pp. 349-356. Date of Electronic Publication: 2021 Apr 14.
Typ publikacji :
Journal Article; Meta-Analysis; Review
MeSH Terms :
Coronary Vessels/*pathology
Percutaneous Coronary Intervention/*methods
ST Elevation Myocardial Infarction/*therapy
Coronary Angiography ; Dilatation, Pathologic/etiology ; Humans ; Incidence ; Myocardial Infarction/etiology ; Percutaneous Coronary Intervention/adverse effects ; ST Elevation Myocardial Infarction/mortality ; Thrombosis/etiology
Czasopismo naukowe
Tytuł :
Comparison of Characteristics and Outcomes of Patients With Acute Myocardial Infarction With Versus Without Coronarvirus-19.
Autorzy :
Case BC; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia.
Yerasi C; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia.
Forrestal BJ; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia.
Shea C; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia.
Rappaport H; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia.
Medranda GA; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia.
Zhang C; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia.
Satler LF; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia.
Ben-Dor I; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia.
Hashim H; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia.
Rogers T; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia; Cardiovascular Branch, Division of Intramural Research, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland.
Waksman R; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia. Electronic address: .
Pokaż więcej
Źródło :
The American journal of cardiology [Am J Cardiol] 2021 Apr 01; Vol. 144, pp. 8-12. Date of Electronic Publication: 2020 Dec 29.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
COVID-19/*complications
Myocardial Infarction/*complications
Aged ; Aged, 80 and over ; COVID-19/diagnosis ; COVID-19/mortality ; Female ; Hospital Mortality ; Humans ; Male ; Middle Aged ; Myocardial Infarction/diagnosis ; Myocardial Infarction/mortality ; Retrospective Studies ; ST Elevation Myocardial Infarction/complications
Czasopismo naukowe
Tytuł :
PACAP-38 in Acute ST-Segment Elevation Myocardial Infarction in Humans and Pigs: A Translational Study.
Autorzy :
Szabo D; Heart Institute, Medical School, University of Pecs, 7624 Pecs, Hungary.; Department of Anatomy, MTA-PTE PACAP Research Team, Centre for Neuroscience, Medical School, University of Pecs, 7624 Pecs, Hungary.
Sarszegi Z; Heart Institute, Medical School, University of Pecs, 7624 Pecs, Hungary.
Polgar B; Department of Medical Microbiology and Immunology, Medical School, University of Pecs, 7624 Pecs, Hungary.
Saghy E; MTA-SE System Pharmacology Research Group and Cardiovascular and Metabolic Research Group, Department of Pharmacology and Pharmacotherapy, Semmelweis University, 1089 Budapest, Hungary.
Nemeth A; Heart Institute, Medical School, University of Pecs, 7624 Pecs, Hungary.
Reglodi D; Department of Anatomy, MTA-PTE PACAP Research Team, Centre for Neuroscience, Medical School, University of Pecs, 7624 Pecs, Hungary.
Makkos A; MTA-SE System Pharmacology Research Group and Cardiovascular and Metabolic Research Group, Department of Pharmacology and Pharmacotherapy, Semmelweis University, 1089 Budapest, Hungary.
Gorbe A; MTA-SE System Pharmacology Research Group and Cardiovascular and Metabolic Research Group, Department of Pharmacology and Pharmacotherapy, Semmelweis University, 1089 Budapest, Hungary.; Pharmahungary Group, 6722 Szeged, Hungary.
Helyes Z; Department of Pharmacology and Pharmacotherapy, Medical School, University of Pecs, 7624 Pecs, Hungary.; Szentagothai Research Centre, University of Pecs, 7624 Pecs, Hungary.; PharmInVivo Ltd., 7629 Pecs, Hungary.
Ferdinandy P; MTA-SE System Pharmacology Research Group and Cardiovascular and Metabolic Research Group, Department of Pharmacology and Pharmacotherapy, Semmelweis University, 1089 Budapest, Hungary.; Pharmahungary Group, 6722 Szeged, Hungary.
Herczeg R; Szentagothai Research Centre, University of Pecs, 7624 Pecs, Hungary.
Gyenesei A; Szentagothai Research Centre, University of Pecs, 7624 Pecs, Hungary.
Cziraki A; Heart Institute, Medical School, University of Pecs, 7624 Pecs, Hungary.
Tamas A; Department of Anatomy, MTA-PTE PACAP Research Team, Centre for Neuroscience, Medical School, University of Pecs, 7624 Pecs, Hungary.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Mar 12; Vol. 22 (6). Date of Electronic Publication: 2021 Mar 12.
Typ publikacji :
Journal Article
MeSH Terms :
Arrhythmias, Cardiac/*blood
Myocardial Infarction/*blood
Pituitary Adenylate Cyclase-Activating Polypeptide/*blood
ST Elevation Myocardial Infarction/*genetics
Aged ; Animals ; Arrhythmias, Cardiac/physiopathology ; Arrhythmias, Cardiac/surgery ; Female ; Glycated Hemoglobin A/genetics ; Heart Ventricles/metabolism ; Heart Ventricles/pathology ; Heart Ventricles/surgery ; Humans ; Male ; Middle Aged ; Myocardial Infarction/genetics ; Myocardial Infarction/pathology ; Myocardial Infarction/surgery ; Non-ST Elevated Myocardial Infarction/blood ; Non-ST Elevated Myocardial Infarction/genetics ; Non-ST Elevated Myocardial Infarction/physiopathology ; Non-ST Elevated Myocardial Infarction/surgery ; Percutaneous Coronary Intervention/adverse effects ; Pituitary Adenylate Cyclase-Activating Polypeptide/genetics ; Risk Factors ; ST Elevation Myocardial Infarction/blood ; ST Elevation Myocardial Infarction/pathology ; ST Elevation Myocardial Infarction/surgery ; Swine ; Treatment Outcome ; Troponin/blood
Czasopismo naukowe
Tytuł :
Comparison of Outcomes with or without Beta-Blocker Therapy After Acute Myocardial Infarction in Patients Without Heart Failure or Left Ventricular Systolic Dysfunction (from the Acute Coronary Syndromes Israeli Survey [ACSIS]).
Autorzy :
El Nasasra A; Department of Cardiology, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, Israel. Electronic address: .
Beigel R; Leviev Heart Center, Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Klempfner R; Leviev Heart Center, Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Alnsasra H; Department of Cardiology, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, Israel.
Matetzky S; Leviev Heart Center, Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Iakobishvili Z; Cardiology Department, Clalit Health Services, Tel Aviv, Israel.
Rubinshtein R; Department of Cardiology, Edith Wolfson Medical Center, Holon and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Halabi M; Department of Cardiology, Ziv Medical Center, Faculty of Medicine, Bar-Ilan University, Tsfat, Israel.
Blatt A; Department of Cardiology, Kaplan Medical Center, Rehovot, Hadassah - Hebrew University School of Medicine, Israel.
Zahger D; Department of Cardiology, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, Israel.
Pokaż więcej
Źródło :
The American journal of cardiology [Am J Cardiol] 2021 Mar 15; Vol. 143, pp. 1-6. Date of Electronic Publication: 2021 Jan 12.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Adrenergic beta-Antagonists/*therapeutic use
Non-ST Elevated Myocardial Infarction/*drug therapy
ST Elevation Myocardial Infarction/*drug therapy
Aged ; Echocardiography ; Female ; Humans ; Ischemic Stroke/epidemiology ; Israel/epidemiology ; Male ; Middle Aged ; Mortality ; Multivariate Analysis ; Myocardial Infarction/drug therapy ; Myocardial Infarction/epidemiology ; Myocardial Ischemia/epidemiology ; Myocardial Revascularization/statistics & numerical data ; Percutaneous Coronary Intervention ; Recurrence ; Stroke Volume
Czasopismo naukowe
Tytuł :
Two-Year Clinical Outcomes Between Prediabetic and Diabetic Patients With STEMI and Multivessel Disease Who Underwent Successful PCI Using Drug-Eluting Stents.
Autorzy :
Kim YH; Division of Cardiology, Department of Internal Medicine, 85082Kangwon National University School of Medicine, Chuncheon, Republic of Korea.
Her AY; Division of Cardiology, Department of Internal Medicine, 85082Kangwon National University School of Medicine, Chuncheon, Republic of Korea.
Jeong MH; Department of Cardiology, 65416Chonnam National University Hospital, Gwangju, Republic of Korea.
Kim BK; Division of Cardiology, Severance Cardiovascular Hospital, 37991Yonsei University College of Medicine, Seoul, Republic of Korea.
Hong SJ; Division of Cardiology, Severance Cardiovascular Hospital, 37991Yonsei University College of Medicine, Seoul, Republic of Korea.
Kim S; Division of Cardiology, 222187Inje University College of Medicine, Haeundae Paik Hospital, Busan, Republic of Korea.
Ahn CM; Division of Cardiology, Severance Cardiovascular Hospital, 37991Yonsei University College of Medicine, Seoul, Republic of Korea.
Kim JS; Division of Cardiology, Severance Cardiovascular Hospital, 37991Yonsei University College of Medicine, Seoul, Republic of Korea.
Ko YG; Division of Cardiology, Severance Cardiovascular Hospital, 37991Yonsei University College of Medicine, Seoul, Republic of Korea.
Choi D; Division of Cardiology, Severance Cardiovascular Hospital, 37991Yonsei University College of Medicine, Seoul, Republic of Korea.
Hong MK; Division of Cardiology, Severance Cardiovascular Hospital, 37991Yonsei University College of Medicine, Seoul, Republic of Korea.
Jang Y; Division of Cardiology, Severance Cardiovascular Hospital, 37991Yonsei University College of Medicine, Seoul, Republic of Korea.
Pokaż więcej
Źródło :
Angiology [Angiology] 2021 Jan; Vol. 72 (1), pp. 50-61. Date of Electronic Publication: 2020 Aug 18.
Typ publikacji :
Comparative Study; Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug-Eluting Stents*
Percutaneous Coronary Intervention*
Diabetes Mellitus/*epidemiology
Prediabetic State/*epidemiology
ST Elevation Myocardial Infarction/*therapy
Age Factors ; Aged ; Cardiopulmonary Resuscitation ; Cohort Studies ; Coronary Artery Disease/mortality ; Coronary Artery Disease/therapy ; Female ; Humans ; Male ; Middle Aged ; Myocardial Infarction/epidemiology ; Republic of Korea/epidemiology ; Retrospective Studies ; ST Elevation Myocardial Infarction/mortality ; Shock, Cardiogenic/epidemiology ; Stroke/epidemiology ; Thrombosis/epidemiology
Czasopismo naukowe
Tytuł :
NT-proBNP level before primary PCI and risk of poor myocardial reperfusion: Insight from the On-TIME II trial.
Autorzy :
Fabris E; Department of Cardiology, Isala Heart Center, Zwolle, The Netherlands; Cardiovascular Department, University of Trieste, Trieste, Italy.
Ten Berg JM; Department of Cardiology, St Antonius Hospital, Nieuwegein, The Netherlands.
Hermanides RS; Department of Cardiology, Isala Heart Center, Zwolle, The Netherlands.
Ottervanger JP; Department of Cardiology, Isala Heart Center, Zwolle, The Netherlands.
Dambrink JHE; Department of Cardiology, Isala Heart Center, Zwolle, The Netherlands.
Gosselink AM; Department of Cardiology, Isala Heart Center, Zwolle, The Netherlands.
Sinagra G; Cardiovascular Department, University of Trieste, Trieste, Italy.
Koopmans PC; Diagram CRO, Zwolle, The Netherlands.
Giannitsis E; Department of Cardiology, Universitats Klinik, Heidelberg, Germany.
Hamm C; Department of Cardiology, Kerckhoff Klinik, Bad Nauheim, Germany.
van 't Hof AWJ; Department of Cardiology, Isala Heart Center, Zwolle, The Netherlands; Maastricht University Medical Center, Department of Cardiology, Maastricht, The Netherlands; Zuyderland Medical Center, Department of Cardiology, Heerlen, The Netherlands. Electronic address: .
Pokaż więcej
Źródło :
American heart journal [Am Heart J] 2021 Mar; Vol. 233, pp. 78-85. Date of Electronic Publication: 2020 Dec 31.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Myocardial Reperfusion*
Biomarkers/*blood
Natriuretic Peptide, Brain/*blood
Peptide Fragments/*blood
ST Elevation Myocardial Infarction/*blood
Adult ; Aged ; Aged, 80 and over ; Anterior Wall Myocardial Infarction/blood ; Anterior Wall Myocardial Infarction/pathology ; Diabetes Mellitus/blood ; Double-Blind Method ; Female ; Fibrinolytic Agents/administration & dosage ; Humans ; Male ; Middle Aged ; Percutaneous Coronary Intervention ; Prospective Studies ; Regression Analysis ; ST Elevation Myocardial Infarction/therapy ; Time-to-Treatment ; Tirofiban/administration & dosage ; Young Adult
Czasopismo naukowe
Tytuł :
Anatomic and Flow Characteristics of Left Anterior Descending Coronary Artery Angiographic Stenoses Predisposing to Myocardial Infarction.
Autorzy :
Katritsis DG; Hygeia Hospital, Athens, Greece. Electronic address: .
Pantos I; Hygeia Hospital, Athens, Greece.
Zografos T; Hygeia Hospital, Athens, Greece.
Spahillari A; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
de Waha A; Deutsches Herzzentrum, München, Germany.
Kopanidis A; Hygeia Hospital, Athens, Greece.
Foussas S; Hygeia Hospital, Athens, Greece.
Stone PH; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Kastrati A; Deutsches Herzzentrum, München, Germany.
Cutlip D; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Pokaż więcej
Źródło :
The American journal of cardiology [Am J Cardiol] 2021 Feb 15; Vol. 141, pp. 7-15. Date of Electronic Publication: 2020 Nov 19.
Typ publikacji :
Journal Article
MeSH Terms :
Hemodynamics*
Coronary Stenosis/*diagnostic imaging
Coronary Thrombosis/*diagnostic imaging
ST Elevation Myocardial Infarction/*diagnostic imaging
Aged ; Coronary Angiography ; Coronary Stenosis/complications ; Coronary Stenosis/physiopathology ; Coronary Thrombosis/etiology ; Coronary Thrombosis/physiopathology ; Coronary Thrombosis/surgery ; Female ; Humans ; Imaging, Three-Dimensional ; Male ; Middle Aged ; Myocardial Infarction/diagnostic imaging ; Myocardial Infarction/etiology ; Myocardial Infarction/physiopathology ; Myocardial Infarction/surgery ; Myocardial Revascularization ; Patient-Specific Modeling ; Retrospective Studies ; ST Elevation Myocardial Infarction/etiology ; ST Elevation Myocardial Infarction/physiopathology ; ST Elevation Myocardial Infarction/surgery ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
Role of antiangiogenic VEGF-A 165 b in angiogenesis and systolic function after reperfused myocardial infarction.
Autorzy :
Ríos-Navarro C; Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain.
Hueso L; Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain.
Díaz A; Unidad Central de Investigación Biomédica (UCIM), Universidad de Valencia, Valencia, Spain.
Marcos-Garcés V; Servicio de Cardiología, Hospital Clínico Universitario de Valencia, Valencia, Spain.
Bonanad C; Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain; Servicio de Cardiología, Hospital Clínico Universitario de Valencia, Valencia, Spain; Departamento de Medicina, Facultad de Medicina y Odontología, Universidad de Valencia, Valencia, Spain.
Ruiz-Sauri A; Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain; Departamento de Patología, Facultad de Medicina y Odontología, Universidad de Valencia, Valencia, Spain.
Vila JM; Departamento de Fisiología, Facultad de Medicina y Odontología, Universidad de Valencia, Valencia, Spain.
Sanz MJ; Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain; Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid, Spain; Departamento de Farmacología, Facultad de Medicina y Odontología, Universidad de Valencia, Valencia, Spain.
Chorro FJ; Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain; Servicio de Cardiología, Hospital Clínico Universitario de Valencia, Valencia, Spain; Departamento de Medicina, Facultad de Medicina y Odontología, Universidad de Valencia, Valencia, Spain; Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
Piqueras L; Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain; Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid, Spain; Departamento de Farmacología, Facultad de Medicina y Odontología, Universidad de Valencia, Valencia, Spain. Electronic address: .
Bodi V; Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain; Servicio de Cardiología, Hospital Clínico Universitario de Valencia, Valencia, Spain; Departamento de Medicina, Facultad de Medicina y Odontología, Universidad de Valencia, Valencia, Spain; Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain. Electronic address: .
Pokaż więcej
Źródło :
Revista espanola de cardiologia (English ed.) [Rev Esp Cardiol (Engl Ed)] 2021 Feb; Vol. 74 (2), pp. 131-139. Date of Electronic Publication: 2020 May 28.
Typ publikacji :
Journal Article
MeSH Terms :
Angiogenesis Inhibitors/*physiology
Angiogenesis Inhibitors/*therapeutic use
Neuroprotective Agents/*metabolism
ST Elevation Myocardial Infarction/*pathology
Vascular Endothelial Growth Factor A/*blood
Animals ; Echocardiography ; Humans ; Mice ; Myocardial Infarction/therapy ; Myocardial Reperfusion ; Neuroprotective Agents/pharmacology ; Stroke Volume ; Vascular Endothelial Growth Factor A/metabolism ; Ventricular Function, Left
Czasopismo naukowe
Tytuł :
Comparison of the Efficacy and Safety of Sacubitril/Valsartan versus Ramipril in Patients With ST-Segment Elevation Myocardial Infarction.
Autorzy :
Rezq A; Department of cardiology, Ain Shams University, Abbassia Square, Cairo, Egypt; Department of cardiology, Dar Al Fouad Hospital, Cairo, Egypt. Electronic address: .
Saad M; Department of cardiology, Ain Shams University, Abbassia Square, Cairo, Egypt; Cardiovascular Institute, Warren Alpert Medical School at Brown University, Providence, Rhode Island.
El Nozahi M; Department of cardiology, Ain Shams University, Abbassia Square, Cairo, Egypt.
Pokaż więcej
Źródło :
The American journal of cardiology [Am J Cardiol] 2021 Mar 15; Vol. 143, pp. 7-13. Date of Electronic Publication: 2021 Jan 06.
Typ publikacji :
Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms :
Percutaneous Coronary Intervention*
Aminobutyrates/*therapeutic use
Angiotensin Receptor Antagonists/*therapeutic use
Angiotensin-Converting Enzyme Inhibitors/*therapeutic use
Ramipril/*therapeutic use
ST Elevation Myocardial Infarction/*drug therapy
Tetrazoles/*therapeutic use
Adult ; Aged ; Double-Blind Method ; Drug Combinations ; Female ; Heart Diseases/mortality ; Heart Failure/epidemiology ; Hospitalization/statistics & numerical data ; Humans ; Male ; Middle Aged ; Myocardial Infarction/epidemiology ; Stroke Volume ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Outcomes of Acute Myocardial Infarction in Patients with Rheumatoid Arthritis.
Autorzy :
Elbadawi A; Department of Cardiovascular Medicine, University of Texas Medical Branch, Galveston.
Ahmed HMA; Division of Rheumatology and Clinial Immunology, University of Alabama at Birmingham, Birmingham. Electronic address: .
Elgendy IY; Division of Cardiology, Massachusetts General Hospital and Harvard Medical School, Boston.
Omer MA; Division of Cardiovascular Medicine, University of Missouri-Kansas City.
Ogunbayo GO; Department of Cardiovascular Medicine, University of Kentucky, Lexington.
Abohamad S; Department of Internal Medicine, Cairo University, Cairo, Egypt. Electronic address: .
Paniagua D; Division of Cardiology, Baylor School of Medicine, Houston, Texas.
Jneid H; Division of Cardiology, Baylor School of Medicine, Houston, Texas. Electronic address: .
Pokaż więcej
Źródło :
The American journal of medicine [Am J Med] 2020 Oct; Vol. 133 (10), pp. 1168-1179.e4. Date of Electronic Publication: 2020 Apr 10.
Typ publikacji :
Journal Article
MeSH Terms :
Arthritis, Rheumatoid/*epidemiology
Hospital Mortality/*trends
Non-ST Elevated Myocardial Infarction/*therapy
ST Elevation Myocardial Infarction/*therapy
Acute Kidney Injury/epidemiology ; Aged ; Aged, 80 and over ; Assisted Circulation ; Blood Coagulation Disorders/epidemiology ; Blood Transfusion/statistics & numerical data ; Chronic Disease ; Comorbidity ; Coronary Artery Bypass/statistics & numerical data ; Coronary Artery Bypass/trends ; Female ; Heart Arrest/epidemiology ; Heart Arrest/etiology ; Hemorrhage/epidemiology ; Hemorrhage/therapy ; Hospitalization ; Humans ; Lung Diseases ; Male ; Middle Aged ; Myocardial Infarction/complications ; Myocardial Infarction/mortality ; Myocardial Infarction/therapy ; Non-ST Elevated Myocardial Infarction/complications ; Non-ST Elevated Myocardial Infarction/mortality ; Patient Discharge ; Percutaneous Coronary Intervention/statistics & numerical data ; Percutaneous Coronary Intervention/trends ; Renal Dialysis/statistics & numerical data ; Renal Insufficiency, Chronic/epidemiology ; Renal Insufficiency, Chronic/therapy ; ST Elevation Myocardial Infarction/complications ; ST Elevation Myocardial Infarction/mortality ; Shock, Cardiogenic/epidemiology ; Shock, Cardiogenic/etiology ; Skilled Nursing Facilities/statistics & numerical data ; United States/epidemiology
Czasopismo naukowe
Tytuł :
[Percutaneous Coronary Interventions in Patients With ST-Elevation Myocardial Infarction: 10-Years Follow-up].
Autorzy :
Bessonov IS; Tyumen Cardiology Research Center, Tomsk National Research Medical Center, Russian Academy of Science, Tomsk.
Kuznetsov VA; Tyumen Cardiology Research Center, Tomsk National Research Medical Center, Russian Academy of Science, Tomsk.
Dyakova AO; Tyumen Cardiology Research Center, Tomsk National Research Medical Center, Russian Academy of Science, Tomsk.
Gorbatenko EA; Tyumen Cardiology Research Center, Tomsk National Research Medical Center, Russian Academy of Science, Tomsk.
Evlampieva LG; Tyumen Cardiology Research Center, Tomsk National Research Medical Center, Russian Academy of Science, Tomsk.
Kicherova OA; Tyumen State Medical University Ministry of Health Russia, Tyumen.
Reikhert LI; Tyumen State Medical University Ministry of Health Russia, Tyumen.
Nyamtsu AM; State Autonomous Institution 'Medical Information-Analytical Centre' 169a, korp. 1 Respubliku St. Tyumen 625023 Russia.
Gultyaeva EP; Tyumen Cardiology Research Center, Tomsk National Research Medical Center, Russian Academy of Science, Tomsk.
Pokaż więcej
Źródło :
Kardiologiia [Kardiologiia] 2020 Jul 07; Vol. 60 (6), pp. 982. Date of Electronic Publication: 2020 Jul 07.
Typ publikacji :
Journal Article
MeSH Terms :
Percutaneous Coronary Intervention*
ST Elevation Myocardial Infarction*
Follow-Up Studies ; Humans ; Myocardial Infarction ; Risk Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Short and Midterm Outcomes in Patients With Acute Myocardial Infarction: Results of the Nationwide TURKMI Registry.
Autorzy :
Kilickap M; Department of Cardiology, 63990Ankara University School of Medicine, Ankara, Turkey.
Erol MK; Department of Cardiology, Sisli International Kolan Hospital, Istanbul, Turkey.
Kayikcioglu M; Department of Cardiology, Faculty of Medicine, 60521Ege University, Izmir, Turkey.
Kocayigit I; Department of Cardiology, Faculty of Medicine, Sakarya University, Sakarya, Turkey.
Gitmez M; Department of Cardiology, Batman Bolge State Hospital, Batman, Turkey.
Can V; Department of Cardiology, 111319Health Science University, Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey.
Besli F; Department of Cardiology, Faculty of Medicine, Harran University, Urfa, Turkey.
Sabanoglu C; Department of Cardiology, Health Science University, Yuksek Ihtisas Training and Research Hospital, Kirikkale, Turkey.
Ungan I; Department of Cardiology, Yalova State Hospital, Yalova, Turkey.
Genc A; Department of Cardiology, Health Science University, Antalya Training and Research Hospital, Antalya, Turkey.
Karatas M; Department of Cardiology, Health Science University, Kartal Kosuyolu Training and Research Hospital, Istanbul, Turkey.
Dursun I; Department of Cardiology, Health Science University, 420101Ahi Evren Training and Research Hospital, Trabzon, Turkey.
Oztekin GMY; Department of Cardiology, Health Science University, Antalya Training and Research Hospital, Antalya, Turkey.
Candemir A; Department of Cardiology, Faculty of Medicine, 60521Ege University, Izmir, Turkey.
Celik Y; Department of Cardiology, Health Science University, Yuksek Ihtisas Training and Research Hospital, Kirikkale, Turkey.
Yanik A; Department of Cardiology, Health Science University, Samsun Training and Research Hospital, Samsun, Turkey.
Halac AHY; Department of Cardiology, Faculty of Medicine, Bezmi Alem University, Istanbul, Turkey.
Akturk IF; Department of Cardiology, Health Science University, Bakirkoy Training and Research Hospital, Istanbul, Turkey.
Sunbul M; Department of Cardiology, Faculty of Medicine, Marmara University, Istanbul, Turkey.
Sarikaya R; Department of Cardiology, Health Science University, Van Training and Research Hospital, Van, Turkey.
Ari H; Department of Cardiology, 111319Health Science University, Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey.
Yalcın AA; Department of Cardiology, Health Science University, İstanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey.
Günes H; Department of Cardiology, Faculty of Medicine, Sutcu Imam University, Kahramanmaras, Turkey.
Pokaż więcej
Źródło :
Angiology [Angiology] 2021 Apr; Vol. 72 (4), pp. 339-347. Date of Electronic Publication: 2020 Nov 25.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Percutaneous Coronary Intervention*/adverse effects
Percutaneous Coronary Intervention*/mortality
Non-ST Elevated Myocardial Infarction/*therapy
ST Elevation Myocardial Infarction/*therapy
Aged ; Coronary Angiography ; Female ; Hospital Mortality ; Humans ; Male ; Middle Aged ; Non-ST Elevated Myocardial Infarction/diagnostic imaging ; Non-ST Elevated Myocardial Infarction/mortality ; Registries ; Risk Assessment ; Risk Factors ; ST Elevation Myocardial Infarction/diagnostic imaging ; ST Elevation Myocardial Infarction/mortality ; Sex Factors ; Time Factors ; Treatment Outcome ; Turkey/epidemiology
Czasopismo naukowe
Tytuł :
NETosis Is Required for S100A8/A9-Induced Granulopoiesis After Myocardial Infarction.
Autorzy :
Nagareddy PR; Division of Cardiac Surgery, Department of Surgery, Ohio State University Wexner Medical Center, Columbus (P.R.N., G.S., R.M.J., J.J., B.A.).
Sreejit G; Division of Cardiac Surgery, Department of Surgery, Ohio State University Wexner Medical Center, Columbus (P.R.N., G.S., R.M.J., J.J., B.A.).
Abo-Aly M; Division of Cardiovascular Medicine, Department of Medicine, University of Kentucky, Lexington (M.A.-A., L.C., A.A.-L.).
Jaggers RM; Division of Cardiac Surgery, Department of Surgery, Ohio State University Wexner Medical Center, Columbus (P.R.N., G.S., R.M.J., J.J., B.A.).
Chelvarajan L; Division of Cardiovascular Medicine, Department of Medicine, University of Kentucky, Lexington (M.A.-A., L.C., A.A.-L.).
Johnson J; Division of Cardiac Surgery, Department of Surgery, Ohio State University Wexner Medical Center, Columbus (P.R.N., G.S., R.M.J., J.J., B.A.).
Pernes G; Division of Immunometabolism, Baker Heart and Diabetes Institute, Melbourne, Australia (G.P., A.J.M.).
Athmanathan B; Division of Cardiac Surgery, Department of Surgery, Ohio State University Wexner Medical Center, Columbus (P.R.N., G.S., R.M.J., J.J., B.A.).
Abdel-Latif A; Division of Cardiovascular Medicine, Department of Medicine, University of Kentucky, Lexington (M.A.-A., L.C., A.A.-L.).
Murphy AJ; Division of Immunometabolism, Baker Heart and Diabetes Institute, Melbourne, Australia (G.P., A.J.M.).
Pokaż więcej
Źródło :
Arteriosclerosis, thrombosis, and vascular biology [Arterioscler Thromb Vasc Biol] 2020 Nov; Vol. 40 (11), pp. 2805-2807. Date of Electronic Publication: 2020 Sep 03.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Leukopoiesis*
Calgranulin A/*metabolism
Calgranulin B/*metabolism
Extracellular Traps/*metabolism
Myocardial Infarction/*metabolism
Neutrophils/*metabolism
Animals ; Calgranulin A/blood ; Calgranulin B/blood ; Case-Control Studies ; Disease Models, Animal ; Humans ; Male ; Mice, Inbred C57BL ; Mice, Knockout ; Myocardial Infarction/immunology ; Myocardial Infarction/pathology ; Neutrophils/immunology ; Neutrophils/pathology ; Non-ST Elevated Myocardial Infarction/blood ; Protein-Arginine Deiminases/deficiency ; Protein-Arginine Deiminases/genetics ; ST Elevation Myocardial Infarction/blood ; Signal Transduction ; Time Factors
Czasopismo naukowe
Tytuł :
Return towards normality in admissions for myocardial infarction after the lockdown removal for COVID-19 outbreak in Italy.
Autorzy :
Rognoni A; Coronary Care Unit and Catheterization Laboratory, A.O.U. Maggiore della Carità, Novara, Italy.
D'Ascenzo F; Division of Cardiology, A.O.U Città della Salute e della Scienza di Torino, Turin, Italy; Department of Medical Sciences, University of Torino, Torino, Italy.
Solli M; Coronary Care Unit and Catheterization Laboratory, A.O.U. Maggiore della Carità, Novara, Italy.
Mennuni MG; Coronary Care Unit and Catheterization Laboratory, A.O.U. Maggiore della Carità, Novara, Italy.
Galiffa V; Coronary Care Unit and Catheterization Laboratory, A.O.U. Maggiore della Carità, Novara, Italy.
Rosso R; Coronary Care Unit and Catheterization Laboratory, A.O.U. Maggiore della Carità, Novara, Italy.
Cavallino C; Division of Cardiology, Presidio Ospedaliero Sant'Andrea di Vercelli, Vercelli, Italy.
Ugo F; Division of Cardiology, Presidio Ospedaliero Sant'Andrea di Vercelli, Vercelli, Italy.
De Filippo O; Division of Cardiology, A.O.U Città della Salute e della Scienza di Torino, Turin, Italy.
Borin A; Division of Cardiology, A.O.U Città della Salute e della Scienza di Torino, Turin, Italy.
Porto I; IRCCS Policlinico San Martino and University of Genova, Italy.
Fedele F; Department of Cardiovascular, Respiratory, Nephrology, Anesthesiology and Geriatric Sciences, Sapienza University of Rome, Italy.
Mancone M; Department of Cardiovascular, Respiratory, Nephrology, Anesthesiology and Geriatric Sciences, Sapienza University of Rome, Italy.
Sardella G; Department of Cardiovascular, Respiratory, Nephrology, Anesthesiology and Geriatric Sciences, Sapienza University of Rome, Italy.
Trabattoni D; Department of Cardiovascular Sciences, IRCCS Centro Cardiologico Monzino, University of Milan, Italy.
Barbero U; Ospedale Civile SS. Annunziata, Savigliano, Italy.
Moncalvo C; Ospedale Civile SS. Annunziata, Savigliano, Italy.
Verardi R; Ospedale Maggiore AUSL, Bologna, Italy.
Casella G; Ospedale Maggiore AUSL, Bologna, Italy.
Montalto C; University of Pavia and Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Leonardi S; University of Pavia and Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Azzolina D; Dipartimento Medicina Traslazionale, Università del Piemonte Orientale, Novara, Italy.
De Ferrari GM; Division of Cardiology, A.O.U Città della Salute e della Scienza di Torino, Turin, Italy; Department of Medical Sciences, University of Torino, Torino, Italy.
Patti G; Coronary Care Unit and Catheterization Laboratory, A.O.U. Maggiore della Carità, Novara, Italy; Dipartimento Medicina Traslazionale, Università del Piemonte Orientale, Novara, Italy. Electronic address: .
Pokaż więcej
Źródło :
International journal of cardiology [Int J Cardiol] 2021 Jun 01; Vol. 332, pp. 235-237. Date of Electronic Publication: 2021 Mar 22.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*
Myocardial Infarction*/diagnosis
Myocardial Infarction*/epidemiology
ST Elevation Myocardial Infarction*/diagnosis
ST Elevation Myocardial Infarction*/epidemiology
ST Elevation Myocardial Infarction*/surgery
Communicable Disease Control ; Disease Outbreaks ; Hospitalization ; Humans ; Italy/epidemiology ; Retrospective Studies ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
Should We Be Using Upstream Beta-Blocker Therapy for Acute Myocardial Infarction?
Autorzy :
Giannakopoulos G; Cardiology Division, Department of Medicine, University Hospital of Geneva, Geneva, Switzerland. .
Noble S; Cardiology Division, Department of Medicine, University Hospital of Geneva, Geneva, Switzerland.
Pokaż więcej
Źródło :
Current cardiology reports [Curr Cardiol Rep] 2021 May 07; Vol. 23 (6), pp. 66. Date of Electronic Publication: 2021 May 07.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Myocardial Infarction*/drug therapy
Percutaneous Coronary Intervention*
ST Elevation Myocardial Infarction*/drug therapy
Adrenergic beta-Antagonists/therapeutic use ; Humans ; Metoprolol/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Patient response, treatments, and mortality for acute myocardial infarction during the COVID-19 pandemic.
Autorzy :
Wu J; Leeds Institute for Data Analytics, University of Leeds, Worsley Building, Level 11, Clarendon Way, University of Leeds, Leeds LS2 9JT, UK.; Division of Clinical and Translational Research, School of Dentistry, University of Leeds, Leeds, UK.
Mamas M; Keele Cardiovascular Research Group, Institute for Prognosis Research, University of Keele, Keele, UK.
Rashid M; Keele Cardiovascular Research Group, Institute for Prognosis Research, University of Keele, Keele, UK.
Weston C; Glangwili General Hospital, Carmarthen, Wales, UK.
Hains J; National Institute for Cardiovascular Outcomes Research, Barts Health NHS Trust, London, UK.
Luescher T; Imperial College, National Heart and Lung Institute, London, UK.
de Belder MA; National Institute for Cardiovascular Outcomes Research, Barts Health NHS Trust, London, UK.
Deanfield JE; National Institute for Cardiovascular Outcomes Research, Barts Health NHS Trust, London, UK.; Institute of Cardiovascular Sciences, University College, London, UK.
Gale CP; Leeds Institute for Data Analytics, University of Leeds, Worsley Building, Level 11, Clarendon Way, University of Leeds, Leeds LS2 9JT, UK.; Leeds Teaching Hospitals NHS Trust, Leeds, UK.; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
Pokaż więcej
Źródło :
European heart journal. Quality of care & clinical outcomes [Eur Heart J Qual Care Clin Outcomes] 2021 May 03; Vol. 7 (3), pp. 238-246.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19*/complications
COVID-19*/epidemiology
COVID-19*/therapy
Non-ST Elevated Myocardial Infarction*/diagnosis
Non-ST Elevated Myocardial Infarction*/mortality
Non-ST Elevated Myocardial Infarction*/therapy
Non-ST Elevated Myocardial Infarction*/virology
ST Elevation Myocardial Infarction*/diagnosis
ST Elevation Myocardial Infarction*/mortality
ST Elevation Myocardial Infarction*/therapy
ST Elevation Myocardial Infarction*/virology
Aged ; Cardiovascular Agents/therapeutic use ; Communicable Disease Control/organization & administration ; Communicable Disease Control/statistics & numerical data ; Coronary Angiography/methods ; Coronary Angiography/statistics & numerical data ; Coronary Artery Bypass/methods ; Coronary Artery Bypass/statistics & numerical data ; Female ; Hospitalization/statistics & numerical data ; Humans ; Male ; Mortality/trends ; Outcome and Process Assessment, Health Care ; Percutaneous Coronary Intervention/methods ; Percutaneous Coronary Intervention/statistics & numerical data ; Registries/statistics & numerical data ; Risk Factors ; SARS-CoV-2/isolation & purification ; Seasons ; United Kingdom/epidemiology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies